ISPOR - Incidence Of Surgery For Inflammatory Bowel Disease Within 12 Months Of Initiation Of Vedolizumab Or Infliximab

Full Text

Incidence Of Surgery For Inflammatory Bowel Disease Within 12 Months Of Initiation Of Vedolizumab Or Infliximab

Abstract

Authors

H Patel M Raluy-Callado A Berger R Carroll JM Khalid

Back to Volume 20, Issue 9

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now